EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2

Show other versions (1)

Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with...

Full description

Bibliographic Details
Main Authors:	Wael H. Roshdy, Helmy A. Rashed, Ahmed Kandeil, Ahmed Mostafa, Yassmin Moatasim, Omnia Kutkat, Noura M. Abo Shama, Mokhtar R. Gomaa, Ibrahim H. El-Sayed, Nancy M. El Guindy, Amal Naguib, Ghazi Kayali, Mohamed A. Ali, Dong-Yan Jin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673558/?tool=EBI

Similar Items

EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.
by: Wael H Roshdy, et al.
Published: (2020-01-01)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
by: Omnia Kutkat, et al.
Published: (2022-07-01)

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors
by: Mokhtar R. Gomaa, et al.
Published: (2020-11-01)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
by: Yassmin Moatasim, et al.
Published: (2023-11-01)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
by: Ahmed Kandeil, et al.
Published: (2020-01-01)

Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
by: Yassmin Moatasim, et al.
Published: (2021-03-01)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Kandeil, et al.
Published: (2021-06-01)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Mostafa, et al.
Published: (2020-12-01)

Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort.
by: Mokhtar R Gomaa, et al.
Published: (2021-03-01)

Insights into Genetic Characteristics and Virological Features of Endemic Avian Influenza A (H9N2) Viruses in Egypt from 2017–2021
by: Mohamed El Sayes, et al.
Published: (2022-07-01)

Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016–2018
by: Ahmed Kandeil, et al.
Published: (2019-01-01)

We are underestimating, again, the true burden of H5N1 in humans
by: Mokhtar Gomaa, et al.
Published: (2023-08-01)

Comparative Virological and Pathogenic Characteristics of Avian Influenza H5N8 Viruses Detected in Wild Birds and Domestic Poultry in Egypt during the Winter of 2016/2017
by: Yassmin Moatasim, et al.
Published: (2019-10-01)

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
by: Mohamed A Ali, et al.
Published: (2017-01-01)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
by: Omnia Kutkat, et al.
Published: (2022-03-01)

Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
by: Amr Kandeel, et al.
Published: (2023-08-01)

Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021
by: Ahmed Kandeil, et al.
Published: (2022-03-01)

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
by: Rabeh El-Shesheny, et al.
Published: (2022-12-01)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
by: Ahmed Kandeil, et al.
Published: (2021-03-01)

Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012
by: Ghazi Kayali, et al.
Published: (2014-04-01)

Insights into the current situation of avian influenza H9N2 viruses circulating in Egypt
by: Ahmed Kandeil, et al.
Published: (2020-03-01)

Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals
by: Ahmed Kandeil, et al.
Published: (2019-01-01)

Diversity of Astroviruses Circulating in Humans, Bats, and Wild Birds in Egypt
by: Ahmed El Taweel, et al.
Published: (2020-04-01)

Development and Evaluation of an Inactivated Influenza A(H5N8) Vaccine
by: Khaled A. Elsharkawy, et al.
Published: (2022-09-01)

Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015–March 2019
by: Mokhtar R. Gomaa, et al.
Published: (2020-09-01)

Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
by: Wael H. Roshdy, et al.
Published: (2022-07-01)

Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
by: Noura M Abo Shama, et al.
Published: (2022-01-01)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
by: Ahmed Mostafa, et al.
Published: (2020-07-01)

Design, Synthesis and In Vitro Evaluation of Spirooxindole-Based Phenylsulfonyl Moiety as a Candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the Implementation of Combination Studies
by: Assem Barakat, et al.
Published: (2022-10-01)

Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
by: Howaida I. Abd-Alla, et al.
Published: (2022-11-01)

Multicenter study to describe viral etiologies, clinical profiles, and outcomes of hospitalized children with severe acute respiratory infections, Egypt 2022
by: Amr Kandeel, et al.
Published: (2023-12-01)

Resurgence of influenza and respiratory syncytial virus in Egypt following two years of decline during the COVID-19 pandemic: outpatient clinic survey of infants and children, October 2022
by: Amr Kandeel, et al.
Published: (2023-06-01)

Genetic and antigenic characterization of avian influenza H9N2 viruses during 2016 in Iraq
by: Nadira S. Mohamed, et al.
Published: (2019-06-01)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
by: Ahmed A. Al-Karmalawy, et al.
Published: (2023-12-01)

Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics
by: Hani A. Alhadrami, et al.
Published: (2021-05-01)

Development of spiro-3-indolin-2-one containing compounds of antiproliferative and anti-SARS-CoV-2 properties
by: Nehmedo G. Fawazy, et al.
Published: (2022-08-01)

Bio-guided chemical characterization and nano-formulation studies of selected edible volatile oils with potential antibacterial and anti-SARS-CoV-2 activities
by: Mohamed S. Refaey, et al.
Published: (2023-07-01)

Epidemiological characterization of viral etiological agents of the central nervous system infections among hospitalized patients in Egypt between 2016 and 2019
by: Wael H. Roshdy, et al.
Published: (2023-08-01)

ALDO-DHF & PARAMOUNT
by: Ahmed M ElGuindy
Published: (2012-12-01)

PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems
by: Ahmed Mostafa, et al.
Published: (2020-09-01)